Chu Yu-Waye
CytomX Therapeutics, Inc. · Chief Medical Officer
Chu Yu-Waye is listed in filings as Chief Medical Officer at CytomX Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to CytomX Therapeutics, Inc. (CTMX). The current snapshot covers public activity from Feb 6, 2025 to Mar 19, 2026. Reported amounts are shown as $136.7K to $253.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.4k4k shares | SellMar 18, 2025 | $0.599 | $3.67 |